BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3141508)

  • 21. Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody.
    Soares M; Havaux X; Nisol F; Bazin H; Latinne D
    J Immunol; 1996 Jan; 156(1):108-18. PubMed ID: 8598450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX; Fu SM; Solanki DL; Rai KR
    J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-linking of the IgM receptor induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton.
    Jugloff LS; Jongstra-Bilen J
    J Immunol; 1997 Aug; 159(3):1096-106. PubMed ID: 9233602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mutation of the mu transmembrane that disrupts endoplasmic reticulum retention. Effects on association with accessory proteins and signal transduction.
    Stevens TL; Blum JH; Foy SP; Matsuuchi L; DeFranco AL
    J Immunol; 1994 May; 152(9):4397-406. PubMed ID: 8157960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement activation by cross-linked B cell-membrane IgM.
    Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
    J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.
    Mond JJ; Seghal E; Kung J; Finkelman FD
    J Immunol; 1981 Sep; 127(3):881-8. PubMed ID: 6790620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies.
    Chen NY; Hung AF; Lin CJ; Chen JB; Chu HM; Yu HM; Chang HY; Chang TW
    Mol Immunol; 2013 Mar; 53(3):187-97. PubMed ID: 22944457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane Ig-cytoskeletal interactions. III. Receptor cross-linking results in the formation of extensive filamentous arrays of vimentin.
    Albrecht DL; Mills JW; Noelle RJ
    J Immunol; 1990 May; 144(9):3251-6. PubMed ID: 2109773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton.
    Chia CP; Khrebtukova I; McCluskey J; Wade WF
    J Immunol; 1994 Oct; 153(8):3398-407. PubMed ID: 7930565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine phosphorylation of components of the B-cell antigen receptors following receptor crosslinking.
    Gold MR; Matsuuchi L; Kelly RB; DeFranco AL
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3436-40. PubMed ID: 1707541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo study of mIgM and mIgD cross-linking on murine B cells.
    Denis O; Macedo-Soares F; Latinne D; Nisol F; Bazin H
    Scand J Immunol; 1994 Jun; 39(6):625-32. PubMed ID: 8009179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-chains of IgM and IgD antigen receptor complexes are differentially N-glycosylated MB-1-related molecules.
    Campbell KS; Hager EJ; Cambier JC
    J Immunol; 1991 Sep; 147(5):1575-80. PubMed ID: 1880417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The riddle of the dual expression of IgM and IgD.
    Geisberger R; Lamers M; Achatz G
    Immunology; 2006 Aug; 118(4):429-37. PubMed ID: 16895553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-induced association of surface immunoglobulin with the detergent insoluble cytoskeleton may involve alpha-actinin.
    Gupta SK; Woda BA
    J Immunol; 1988 Jan; 140(1):176-82. PubMed ID: 3257227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abortive activation of B lymphocytes by monoclonal anti-immunoglobulin antibodies.
    Cambier JC; Heusser CH; Julius MH
    J Immunol; 1986 May; 136(9):3140-6. PubMed ID: 3485681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane immunoglobulin-cytoskeletal interactions--II. Biochemical analysis of cytoskeletally associated IgM.
    Albrecht DL; Noelle RJ
    Mol Immunol; 1989 Jun; 26(6):575-82. PubMed ID: 2788805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling.
    van Horssen M; Loman S; Rijkers GT; Boom SE; Bloem AC
    Eur J Immunol; 1995 Jan; 25(1):154-8. PubMed ID: 7843226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane Ig.
    Martel F; Bazin R; Verrette S; Lemieux R
    J Immunol; 1988 Sep; 141(5):1624-9. PubMed ID: 3261755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligation of CD45 on B cells can facilitate production of secondary Ig isotypes.
    George A; Rath S; Shroff KE; Wang M; Durdik JM
    J Immunol; 1994 Feb; 152(3):1014-21. PubMed ID: 8301113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.